Literature DB >> 13679460

Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.

Chih-Yi Hsu1, Donald Ming-Tak Ho, Ching-Fen Yang, Hung Chiang.   

Abstract

MIB-1 labeling index has been used as a complementary method to differentiate better and worse prognostic groups of astrocytic tumors. However, its reproducibility has been doubted because of the interlaboratory and interobserver variability. We studied the interobserver reproducibility of four manual counting methods of MIB-1 labeling index, including direct counting, area fraction, line intersection with a graticule, and line intersection without a graticule to estimate the total number of the cells. Using line intersection estimate, either with or without a graticule, yielded a worse result. Those MIB-1 labeling indices of astrocytomas were overlapping with those of anaplastic astrocytomas and glioblastomas. Besides, the intraclass correlation coefficient was smaller, and the coefficient of variation was greater than that attained when using a graticule and counting the total number of cells either directly or by area-fraction estimate. The level of interobserver agreement using an MIB-1 labeling index cutoff value of 11.0 was moderate to substantial when applying the line-intersection estimate, and it was almost perfect when applying the direct counting or the area-fraction estimate. The interobserver reproducibility and agreement of MIB-1 labeling index in astrocytic tumors were different depending on the counting methods. Direct counting with a graticule yielded the best result. Before establishing reference standards for staining and counting, the reproducibility of MIB-1 labeling index should be verified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679460     DOI: 10.1097/01.MP.0000084631.64279.BC

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

1.  What is better/reliable, mitosis counting or Ki67/MIB1 staining?

Authors:  Mark Kriegsmann; Arne Warth
Journal:  Transl Lung Cancer Res       Date:  2016-10

2.  Clinical features and surgical management of intracranial meningiomas in the elderly.

Authors:  Junkoh Yamamoto; Mayu Takahashi; Masaru Idei; Yoshiteru Nakano; Yoshiteru Soejima; Daisuke Akiba; Takehiro Kitagawa; Kunihiro Ueta; Ryo Miyaoka; Shigeru Nishizawa
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

3.  Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.

Authors:  Linda R Margraf; Lynn Gargan; Yasmeen Butt; Nirupa Raghunathan; Daniel C Bowers
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

4.  Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach.

Authors:  Tina Zahel; Sabine Krysa; Esther Herpel; Albrecht Stenzinger; Benjamin Goeppert; Peter Schirmacher; Hans Hoffmann; Philipp A Schnabel; Arne Warth
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

5.  Condensed chromatin staining of CKAP2 as surrogate marker for mitotic figures.

Authors:  Han-Seong Kim; Yong-Bock Choi; Jung-Hwa Lee; Seong-Yeol Park; Hyun-Kyoung Kim; Jae-Soo Koh; Sang-Yeop Yi; Kyung-Tae Kim; Kyung-Uk Hong; Joobae Park; Chang-Dae Bae; Kyeong-Man Hong
Journal:  J Cancer Res Clin Oncol       Date:  2011-10-22       Impact factor: 4.553

6.  Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors.

Authors:  Annika Blank; Laura Wehweck; Ilaria Marinoni; Laura Amanda Boos; Frank Bergmann; Anja Maria Schmitt; Aurel Perren
Journal:  Virchows Arch       Date:  2015-09-17       Impact factor: 4.064

7.  Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids.

Authors:  Arne Warth; Ludger Fink; Annette Fisseler-Eckhoff; Danny Jonigk; Marius Keller; German Ott; Ralf J Rieker; Peter Sinn; Stephan Söder; Alex Soltermann; Klaus Willenbrock; Wilko Weichert
Journal:  Virchows Arch       Date:  2013-04-05       Impact factor: 4.064

8.  Patterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling index.

Authors:  Kazuyuki Uehara; Takashi Sasayama; Daisuke Miyawaki; Hideki Nishimura; Kenji Yoshida; Yoshiaki Okamoto; Naritoshi Mukumoto; Hiroaki Akasaka; Masamitsu Nishihara; Osamu Fujii; Toshinori Soejima; Kazuro Sugimura; Eiji Kohmura; Ryohei Sasaki
Journal:  Radiat Oncol       Date:  2012-06-26       Impact factor: 3.481

9.  Quantitative analysis of cancer-associated gene methylation connected to risk factors in Korean colorectal cancer patients.

Authors:  Ho-Jin Kang; Eun-Jeong Kim; Byoung-Gwon Kim; Chang-Hun You; Sang-Yong Lee; Dong-Il Kim; Young-Seoub Hong
Journal:  J Prev Med Public Health       Date:  2012-07-31

10.  Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers.

Authors:  Anna S Berghoff; Harald Stefanits; Adelheid Woehrer; Harald Heinzl; Matthias Preusser; Johannes A Hainfellner
Journal:  Clin Neuropathol       Date:  2013 May-Jun       Impact factor: 1.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.